These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 34346174

  • 1. Periconceptional nonsteroidal anti-inflammatory drug use, folic acid intake, and the risk of spina bifida.
    Esposito DB, Parker SE, Mitchell AA, Tinker SC, Werler MM.
    Birth Defects Res; 2021 Oct 15; 113(17):1257-1266. PubMed ID: 34346174
    [Abstract] [Full Text] [Related]

  • 2. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects.
    Kerr SM, Parker SE, Mitchell AA, Tinker SC, Werler MM.
    Ann Epidemiol; 2017 Dec 15; 27(12):777-782.e1. PubMed ID: 29133009
    [Abstract] [Full Text] [Related]

  • 3. Folic acid intake and spina bifida in the era of dietary folic acid fortification.
    Ahrens K, Yazdy MM, Mitchell AA, Werler MM.
    Epidemiology; 2011 Sep 15; 22(5):731-7. PubMed ID: 21659881
    [Abstract] [Full Text] [Related]

  • 4. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida.
    Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM.
    Am J Obstet Gynecol; 2013 Sep 15; 209(3):239.e1-8. PubMed ID: 23711668
    [Abstract] [Full Text] [Related]

  • 5. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida.
    Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ.
    Am J Epidemiol; 1998 Jul 01; 148(1):30-7. PubMed ID: 9663401
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maternal periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case-control study.
    De Marco P, Merello E, Calevo MG, Mascelli S, Pastorino D, Crocetti L, De Biasio P, Piatelli G, Cama A, Capra V.
    Childs Nerv Syst; 2011 Jul 01; 27(7):1073-81. PubMed ID: 21207040
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems.
    Lary JM, Edmonds LD.
    MMWR CDC Surveill Summ; 1996 Apr 19; 45(2):15-26. PubMed ID: 8602137
    [Abstract] [Full Text] [Related]

  • 12. Folic acid and prevention of neural tube defects: a study of Canadian mothers of infants with spina bifida.
    Forman R, Singal N, Perelman V, Chou S, Hoffman L, Parkin P, Koren G.
    Clin Invest Med; 1996 Jun 19; 19(3):195-201. PubMed ID: 8724823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.
    Atta CA, Fiest KM, Frolkis AD, Jette N, Pringsheim T, St Germaine-Smith C, Rajapakse T, Kaplan GG, Metcalfe A.
    Am J Public Health; 2016 Jan 19; 106(1):e24-34. PubMed ID: 26562127
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spina bifida and other neural tube defects.
    Northrup H, Volcik KA.
    Curr Probl Pediatr; 2000 Jan 19; 30(10):313-32. PubMed ID: 11147289
    [Abstract] [Full Text] [Related]

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.
    Volcik KA, Shaw GM, Lammer EJ, Zhu H, Finnell RH.
    Birth Defects Res A Clin Mol Teratol; 2003 Mar 01; 67(3):154-7. PubMed ID: 12797455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.